Stock Taper 
APYX
$3.12
▲ UP 2.97% (0.09)
KEY STATISTICS
Market Cap$131.38 M
52w High$5.08
52w Low$1.70
Dividend Yield—
Frequency—
P/E-15.60
Volume52.89K
Shares Out.42.11M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Charles D. Goodwin
COMPENSATION 2026
Salary$501,800
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$501,800
ABOUT
SECTOR
Healthcare
WENT PUBLIC
January 2, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
205
PRICE TARGET
Target High$7.00
Target Low$6.00
Target Median$6.50
Target Consensus$6.50
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$13.30M
NOV
5
THU
PRICE
$3.12 ▲ UP 2.97% (+$0.09)About Apyx Medical Corporation
https://apyxmedical.com ↗Apyx Medical Corporation develops and sells advanced energy medical devices, including Helium Plasma Generators and Renuvion products, for cosmetic and surgical markets worldwide.
INDUSTRY
Medical - Specialties
A PRODUCT APYX MEDICAL CORPORATION IS KNOWN FOR
AYON Body Contouring System
The AYON Body Contouring System by Apyx Medical is an FDA-cleared, all-in-one platform integrating fat removal, tissue contraction with Renuvion helium plasma, and electrosurgical tools for comprehensive aesthetic body contouring.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | OEM | $1.81M | $2.45M ▲ | $1.76M ▼ | $1.5M ▼ |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | UNITED STATES | $9.33M | $14.95M ▲ | $8.11M ▼ | $9.41M ▲ |
 | NonUS | $3.54M | $4.21M ▲ | $4.38M ▲ | $4.48M ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
13
LISTED HERE
3
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
45.06%
HOLDERS
101
TOP 12 OF 101 · RANKED BY POSITION SIZE
Nantahala Capital Management, LLC
Archon Capital Management LLC
Royce & Associates LP
Vanguard Group Inc
Essex Investment Management Co LLC
Aigh Capital Management LLC
Silverberg Bernstein Capital Management LLC
Invenire Partners, LP
Cortina Asset Management, LLC
Commonwealth Equity Services, LLC
Horizon Kinetics Asset Management LLC
Cowen Prime Advisors LLC
RATINGS SNAPSHOT
Overall rating: D+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
DIRECTOR
Waldman Lawrence
Sale · 5.0K shares
2026-06-30
★
DIRECTOR
Waldman Lawrence
Sale · 12.0K shares
2026-06-30
★
DIRECTOR
Waldman Lawrence
Purchase · 12.0K shares
2026-06-30
★
OFFICER: CHIEF OPERATING OFFICER
Roman Shawn David
Purchase · 15.0K shares
2026-06-15
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
MARKET OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 RCEL | $10.06 | COMPARE |
 PDEX | $65.67 | COMPARE |
 LUCD | $0.96 | COMPARE |
 VANI | $1.38 | COMPARE |
 SERA | $2.14 | COMPARE |
 RPID | $1.68 | COMPARE |
 NSPR | $0.90 | COMPARE |
 ATOS | $2.54 | COMPARE |